DCM
RDY icon

Deuterium Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Deuterium Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,175
Closed -$267K – 96
2023
Q2 		$267K Buy
21,175
+995
+5% +$11.6K 0.35% 53
2023
Q1 		$230K Buy
+20,180
New +$218K 0.36% 64

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Deuterium Capital Management's RDY Position: Q3 2023 in Review

Deuterium Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2023, closing a stake of 21,175 shares — an estimated $267K sold.

Deuterium Capital Management first reported a position in RDY in Q1 2023 and held it in 2 quarters. The position peaked at $267K in Q2 2023. 212 funds tracked by Wall St. Rank hold RDY as of Q3 2023.

  • Deuterium Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 21,175 Dr. Reddy's Laboratories shares in Q3 2023, an estimated $267K.
  • Deuterium Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 2 quarters.
  • Deuterium Capital Management's Dr. Reddy's Laboratories position peaked at $267K in Q2 2023.
  • 212 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2023.

Based on Deuterium Capital Management's 13F filing for Q3 2023, filed 31 Oct 2023.